BSE filing, BSE: 531262. Summary written from the filing by ALFA Finder's alert engine.
Equilateral Enterprises Ltd: key numbers
- Share price
- ₹8.45
- Market cap
- ₹10.42 Cr
- Revenue (annual)
- ₹58.78 Cr
- Net profit (annual)
- ₹0.24 Cr
- P/E (TTM)
- 85.1×Sector 41.7×
- Promoter holding
- 8.04%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Equilateral Enterprises Ltd
All →Equilateral Enterprises Annual General Meeting
Equilateral Enterprises Limited held its 39th Annual General Meeting on September 29, 2026, to conduct routine business and approve related party transactions.
Equilateral Enterprises Annual General Meeting
Equilateral Enterprises Limited has scheduled its 39th Annual General Meeting for September 29, 2026, to conduct routine business, including shareholder approval of related party transactions.
Equilateral Enterprises Annual Report
Equilateral Enterprises Limited has submitted its 39th Annual Report for the Financial Year 2025-26.
Equilateral Enterprises Other Announcement
Equilateral Enterprises Limited has approved the re-appointment of M/s. SSRV and Associates as Statutory Auditors. The second five-year term commences from the 39th AGM through the 44th AGM.
- Execution
- 5 years
Equilateral Enterprises Board Meeting Outcome
Equilateral Enterprises Limited's board approved a Rs. 100.00 crore material related party transaction. The board also recommended the re-appointment of its Managing Director and statutory auditors.
- Value
- ₹100.0 Cr
Equilateral Enterprises Board Meeting Date
Equilateral Enterprises Limited has scheduled a Board Meeting for September 2, 2026. The board will consider the 39th AGM notice, director re-appointments, and related party transaction limits.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.